The non-BRAF/non-RAS subtype was associated with less aggressive thyroid cancer, with a follicular growth pattern and mutations of EIF1A, PTEN, DICER1, EZH1, SOS1, IDH1, and SPOP, PPARG fusion, and THADA fusion [8]. Here, BRAF is linked to thyroid cancer.